Economic Burden of Recurrence in Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer: A Retrospective Study Using Nationwide Claims Data of South Korea

Introduction Although many patients with early stage non-small cell lung cancer (NSCLC) experience recurrence despite complete resection, few studies have reported on the corresponding economic burden. This study aimed to understand the economic impact of recurrence by measuring healthcare costs and...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Advances in therapy 2023-02, Vol.40 (2), p.550-567
Hauptverfasser:	Byun, Joo-Young, Lee, Ju-Eun, Shim, Yoon-Bo, Kim, Jihyun, Lee, Sun Young, Shin, Bo Ra, Yoon, Na Ri, Park, Mi-Hai, Lee, Eui-Kyung
Format:	Artikel
Sprache:	eng
Schlagworte:	Carcinoma, Non-Small-Cell Lung - drug therapy Cardiology Endocrinology Financial Stress Health Care Costs Humans Internal Medicine Lung Neoplasms - drug therapy Medicine Medicine & Public Health Oncology Original Research Pharmacology/Toxicology Retrospective Studies Rheumatology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!